Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials.
Chia Siang Chia KowAmaan JavedDinesh Sangarran RamachandramSyed Shahzad HasanPublished in: Expert review of anti-infective therapy (2021)
Sofosbuvir-based direct-acting antiviral agents have no protective effects against the development of severe illness in patients with COVID-19 with the current dosing regimen. Whether sofosbuvir-based direct-acting antiviral agents could offer mortality benefits would require further investigations.